X4 Pharmaceuticals (XFOR)
(Delayed Data from NSDQ)
$0.70 USD
+0.01 (1.55%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.70 0.00 (-0.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | -52.94% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.55 |
Next Year | -0.45 |
EPS (TTM) | -0.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 52.98M | 1.79M | 24.76M | 51.45M |
# of Estimates | 2 | 6 | 6 | 6 |
High Estimate | 105.19M | 3.50M | 115.55M | 140.70M |
Low Estimate | 0.77M | 0.75M | 2.50M | 9.33M |
Year ago Sales | 0.00M | 0.00M | NA | 24.76M |
Year over Year Growth Est. | NA | NA | NA | 107.82% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | -0.17 | -0.55 | -0.45 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | 0.34 | -0.17 | -0.21 | -0.10 |
High Estimate | 0.34 | -0.17 | -0.21 | -0.10 |
Low Estimate | -0.24 | -0.18 | -0.80 | -0.70 |
Year ago EPS | -0.33 | -0.01 | -0.57 | -0.55 |
Year over Year Growth Est. | 84.85% | -1,600.00% | 3.51% | 18.31% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.05 | -0.17 | -0.55 | -0.45 |
7 Days Ago | -0.05 | -0.17 | -0.55 | -0.45 |
30 Days Ago | -0.05 | -0.17 | -0.55 | -0.44 |
60 Days Ago | -0.05 | -0.17 | -0.55 | -0.44 |
90 Days Ago | -0.11 | -0.17 | -0.47 | -0.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.17 | -0.55 | -0.10 |
Zacks Consensus Estimate | -0.05 | -0.17 | -0.55 | -0.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 77.53% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.10 | -0.01 | -0.33 | NA |
Estimate | -0.17 | -0.15 | -0.15 | -0.17 | NA |
Difference | -0.09 | 0.05 | 0.14 | -0.16 | -0.02 |
Surprise | -52.94% | 33.33% | 93.33% | -94.12% | -5.10% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more